Last Updated: April 30, 2026

VANTIVE US Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for VANTIVE US

VANTIVE US has six approved drugs.



Summary for VANTIVE US
US Patents:0
Tradenames:37
Ingredients:4
NDAs:6

Drugs and US Patents for VANTIVE US

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vantive Us Hlthcare DIANEAL LOW CALCIUM W/ DEXTROSE 3.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 020183-003 Dec 4, 1992 DISCN Yes No ⤷  Start Trial ⤷  Start Trial
Vantive Us Hlthcare DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 020183-002 Dec 4, 1992 AT RX Yes No ⤷  Start Trial ⤷  Start Trial
Vantive Us Hlthcare PRISMASOL BGK 2/0 IN PLASTIC CONTAINER calcium chloride; dextrose; lactic acid; magnesium chloride; potassium chloride; sodium bicarbonate; sodium chloride INJECTABLE;INJECTION 021703-002 Oct 25, 2006 RX Yes Yes ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VANTIVE US

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vantive Us Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 6,077,836 ⤷  Start Trial
Vantive Us Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 4,761,237 ⤷  Start Trial
Vantive Us Hlthcare EXTRANEAL icodextrin SOLUTION;INTRAPERITONEAL 021321-001 Dec 20, 2002 6,248,726 ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.